Antimicrobial properties of analgesic kyotorphin peptides unraveled through atomic force microscopy

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 676-679

  Ribeiro, Marta M B ^a   Franquelim, Henri G ^a   Torcato, Inês M ^a   Ramu, Vasanthakumar G ^b   Heras, Montserrat ^b   Bardaji, Eduard R ^b   Castanho, Miguel A R B ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF GIRONA   (Spain)

Author keywords

Analgesic; Antimicrobial; Atomic force microscopy; Hemolytic; Kyotorphin derivatives; Peptide

Indexed keywords

ANTIBIOTIC AGENT; KYOTORPHIN;

AMIDATION; ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL DISRUPTION; CONTROLLED STUDY; CYTOLYSIS; ERYTHROCYTE; ESCHERICHIA COLI; LIPID MEMBRANE; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANALGESICS; ANTI-INFECTIVE AGENTS; CELLS, CULTURED; ENDORPHINS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; ESCHERICHIA COLI; HUMANS; IBUPROFEN; MICROSCOPY, ATOMIC FORCE; STAPHYLOCOCCUS AUREUS;

BOVINAE; STAPHYLOCOCCUS AUREUS;

EID: 84859587507     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.065     Document Type: Article

References (23)

1. Melo M.N., Ferre R., Castanho M.A. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol. 2009, 7:245-250.
2. Henriques S.T., Melo M.N., Castanho M.A. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem J. 2006, 399:1-7.
3. Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999, 1462:11-28.
4. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1992, 1121:130-136.
5. Mine Y., Ma F., Lauriau S. Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. J. Agric. Food Chem. 2004, 52:1088-1094.
6. Froidevaux R., Krier F., Nedjar-Arroume N., Vercaigne-Marko D., Kosciarz E., Ruckebusch C., Dhulster P., Guillochon D. Antibacterial activity of a pepsin-derived bovine hemoglobin fragment. FEBS Lett. 2001, 491:159-163.
7. Nedjar-Arroume N., Dubois-Delval V., Miloudi K., Daoud R., Krier F., Kouach M., Briand G., Guillochon D. Isolation and characterization of four antibacterial peptides from bovine hemoglobin. Peptides 2006, 27:2082-2089.
8. Daoud R., Dubois V., Bors-Dodita L., Nedjar-Arroume N., Krier F., Chihib N.E., Mary P., Kouach M., Briand G., Guillochon D. New antibacterial peptide derived from bovine hemoglobin. Peptides 2005, 26:713-719.
9. Nedjar-Arroume N., Dubois-Delval V., Adje E.Y., Traisnel J., Krier F., Mary P., Kouach M., Briand G., Guillochon D. Bovine hemoglobin: an attractive source of antibacterial peptides. Peptides 2008, 29:969-977.
10. Adje E.Y., Balti R., Kouach M., Dhulster P., Guillochon D., Nedjar-Arroume N. Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin. Int. J. Biol. Macromol. 2011, 49:143-153.
11. Catiau L., Traisnel J., Chihib N.E., Le Flem G., Blanpain A., Melnyk O., Guillochon D., Nedjar-Arroume N. RYH: a minimal peptidic sequence obtained from beta-chain hemoglobin exhibiting an antimicrobial activity. Peptides 2011, 32:1463-1468.
12. Catiau L., Traisnel J., Delval-Dubois V., Chihib N.E., Guillochon D., Nedjar-Arroume N. Minimal antimicrobial peptidic sequence from hemoglobin alpha-cha: KYR. Peptides 2011, 32:633-638.
13. Takagi H., Shiomi H., Ueda H., Amano H. Morphine-like analgesia by a new dipeptide, l-tyrosyl-l-arginine (kyotorphin) and its analogue. Eur. J. Pharmacol. 1979, 55:109-111.
14. Ribeiro M.M., Pinto A.R., Domingues M.M., Serrano I., Heras M., Bardaji E.R., Tavares I., Castanho M.A. Chemical conjugation of the neuropeptide kyotorphin and ibuprofen enhances brain targeting and analgesia. Mol. Pharm. 2011, 8:1929-1940.
15. Ribeiro M.M., Pinto A., Pinto M., Heras M., Martins I., Correia A., Bardaji E., Tavares I., Castanho M. Inhibition of nociceptive responses after systemic administration of amidated kyotorphin. Br. J. Pharmacol. 2011, 163:964-973.
16. Alves C.S., Melo M.N., Franquelim H.G., Ferre R., Planas M., Feliu L., Bardaji E., Kowalczyk W., Andreu D., Santos N.C., Fernandes M.X., Castanho M.A. Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. J. Biol. Chem. 2010, 285:27536-27544.
17. Henriques S.T., Huang Y.H., Rosengren K.J., Franquelim H.G., Carvalho F.A., Johnson A., Sonza S., Tachedjian G., Castanho M.A., Daly N.L., Craik D.J. Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. J. Biol. Chem. 2011, 286:24231-24241.
18. Huang Y.H., Colgrave M.L., Clark R.J., Kotze A.C., Craik D.J. Lysine-scanning mutagenesis reveals an amendable face of the cyclotide kalata B1 for the optimization of nematocidal activity. J. Biol. Chem. 2010, 285:10797-10805.
19. Tosteson M.T., Holmes S.J., Razin M., Tosteson D.C. Melittin lysis of red cells. J. Membr. Biol. 1985, 87:35-44.
20. Nowakowski R., Luckham P., Winlove P. Imaging erythrocytes under physiological conditions by atomic force microscopy. Biochim. Biophys. Acta 2002, 1514:170-176.
21. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J. 1993, 294(Pt 1):1-14.
22. Iglic A., Kralj-Iglic V., Hagerstrand H. Amphiphile induced echinocyte-spheroechinocyte transformation of red blood cell shape. Eur. Biophys. J. 1998, 27:335-339.
23. M. Manrique-Moreno, F. Villena, C.P. Sotomayor, A.M. Edwards, M.A. Munoz, P. Garidel, M. Suwalsky, Human cells and cell membrane molecular models are affected in vitro by the nonsteroidal anti-inflammatory drug ibuprofen, Biochim. Biophys. Acta 1808 (2011) 2656-2664.